Latest Prescription Drugs news
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
posted March 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
Pelabresib Plus Ruxolitinib Improves Underlying Myelofibrosis
posted March 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Heart Failure Patients With Ejection Fraction Improvement Rarely Withdrawn From Meds
posted March 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Gantenerumab May Slow Decline in Dominantly Inherited Alzheimer Disease
posted March 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
More Extensive Deposits of Tau Seen in Early-Onset Alzheimer Disease 
CTE Pathology Found in Nearly 75 Percent of Deceased Former NFL Players 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing Monthly Specialist Briefings
Stay Connected
